Inventor
BYUNG-CHUL SUH
Inventor
US
Overview
Patents· 10 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds31%
A61KPreparations for medical, dental or toiletry purposes28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations22%
C07BGeneral methods of organic chemistry9%
C07CAcyclic or carbocyclic compounds9%
PatentTitleYear
12,496,282Hepatitis B antiviral agents202512,398,147Macrocyclic spiropyrrolidine derived antiviral agents2025RE050528Compounds and compositions for modulating EGFR mutant kinase activities202512,258,3275-membered heteroaryl-containing aminopyridine compounds as EGFR inhibitors202512,011,425Hepatitis B antiviral agents202411,945,798Substituted aminopyridine compounds as EGFR inhibitors202411,760,755Hepatitis B antiviral agents202311,596,611Hepatitis B antiviral agents202311,472,808Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents202211,236,111Hepatitis B antiviral agents2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to ENANTA PHARM INC (7)· patent assignee history
2022–2025Based in US· patent location history
2024–2025Patents assigned to YUHAN CORP (3)· patent assignee history
2024–2025Patents assigned to JANSSEN BIOTECH INC (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| ENANTA PHARM INC | 7 | 2022–2025 |
| YUHAN CORP | 3 | 2024–2025 |
| JANSSEN BIOTECH INC | 2 | 2024–2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 10 | 2022–2025 |